They have a product in phase 3 for HCC and one in phase 2 for colon cancer with some positive news and other interesting compounds. They have probably 18 months of cash . At a 1.50 seems like the risk reward is inviting.
Attracted by the news which seems promising. However it is very evident they do not funds to run a phase 3 and at the current run rate will be out of cash in 18 months. Take it to the bank they will raise funds and there will be major dilution here and SOON. That will be the time to buy . Have seen this scenario many times; I do think the company has a potentially great future but there will be better time to buy
Would love to see some on this board. With the stock up almost 50% since Feb10 and approximately 20% of the float exchanging hands , on no news, does anyone have a plausible explanation other than some entity taking a position either as an activist or as a prelude to a possible takeover..